Fitbits Estimated Oxygen Variation Graph Now Available To All

Food and Healthcare Press Releases Wednesday March 4, 2020 10:07
Bangkok--4 Mar--FleishmanHillard

Fitbit’s new Estimated Oxygen Variation graph is available now to all Charge 3, Ionic, Versa, Versa Lite, and Versa 2 users. This new feature, which we originally announced at our August launch event and began rolling out to some users in January, utilizes the red and infrared sensors on the back of the device to estimate the variability in your blood oxygen saturation level.

The graph, which users can see in the Fitbit app under the Sleep tile, approximates the changes in your blood oxygen saturation while you sleep. Blood oxygen saturation measures the percent of your blood that’s saturated with oxygen. Typically, it’s at 95-100%, meaning the blood is carrying as much oxygen as it can. If you stop breathing or have other lung issues, the saturation level can fall since less oxygen enters the body. In general, variations should be low and seeing frequent, big variations could be a sign that you may be experiencing breathing disturbances during sleep.

The graph is another example of our commitment to providing more useful data to our users, but it is not intended for medical purposes. You should always consult your health care professional about any questions or health issues you may have.


Latest Press Release

Ansell Urges Global Priority For Supply Of Personal Protective Equipment

Ansell Limited, a global leader in protective solutions, is working with governments and health organizations worldwide to ensure unrestricted personal protective equipment (PPE) manufacture and supply is given top priority during the COVID-19...

Yiling Pharmacy Lianhua Qingwen has been approved by the Thai FDA

On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the Food and Drug Administration of Thailand. Lianhua Qingwen Capsule is recognized as in...

EW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions

Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as...

Saxenda(R) Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity

Novo Nordisk today announced that the New England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda(R) (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted...

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020 Johnson & Johnson...

Related Topics